JPIFUND - Key Persons


ANNA RUSEK - CFO

Job Titles:
  • FINANCIAL DIRECTOR
Responsible for shaping financial and investment strategy of JPIF. In charge of finance and accounting management, as well as supervising internal and external audit, and financial risk. With over 11 years of experience in the financial sector. She specializes in international and local accounting standards and financial reporting. Chartered auditor, continuing to gain ACCA qualifications.

DOROTA GRONDZIEL

Job Titles:
  • OFFICE MANAGER
Ms Grondziel manages the office of the Fund. Before JPIF, she worked in various fields, including reporting, real estate, office management, IT recruitment and customer service where she gained significant experience within administrative management and collaboration with contractors and clients.

Dr. Axel Polack

Job Titles:
  • GENERAL PARTNER
  • General Partner at the Joint Polish Investment Fund
Dr. Axel Polack is a General Partner at the Joint Polish Investment Fund. Before JPIF Dr. Polack was from 2000 to 2014 a key member of the Life Science team at TVM Capital, which raised more than 680m in venture capital and accomplished 67 investments, 18 IPOs ("initial public offerings") and 15 trade sales. Prior to his career in venture capital he was involved in business management as General Manager and basic biomedical research as Deputy Chairman of a large research institute. He has a proven track record in venture capital and early stage company building.

KRESKE NICKELSEN - CEO

Job Titles:
  • CEO
  • GENERAL PARTNER
Ms Nickelsen is a venture capital professional with more than 18 years of supervisory board and investment experience in companies based all over Europe. Before JPIF, Ms Nickelsen was a partner at Aescap, a life science venture capital fund based in Amsterdam (www.Aescap.com), and before that a director at 3i Group plc in London (www.3igroup.com). She holds an MBA from INSEAD (France) and a Masters in Biology from Philipps University Marburg (Germany).

MAREK ORŁOWSKI

Job Titles:
  • GENERAL PARTNER
Co-Founder of Nepentes SA, a manufacturer and supplier of pharmaceuticals. In 1997 IPO on WSE and in 2010 Sale to Sanofi-Aventis for about 106M. Since 2010 active as business angel investing in life-science companies in Poland and abroad.